HIV-1-infected long-term slow progressors heterozygous for Δ32-CCR5 show significantly lower plasma viral load than wild-type slow progressors

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 18, Issue 3, 1998, Pages 229-233

  Walli, Ravi ^a   Reinhart, Brigitte ^a   Luckow, Bruno ^a   Lederer, Erich ^a   Loch, Oliver ^a   Malo, Antje ^b   Wank, Rudolf ^b   Schlöndorff, Detlef ^a   Goebel, Frank D ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

CCR5; Chemokine receptors; Disease progression; HIV 1; Long term nonprogressors; Plasma viral load

Indexed keywords

CHEMOKINE RECEPTOR; RANTES;

ARTICLE; BLOOD SAMPLING; DISEASE COURSE; DNA HYBRIDIZATION; DRUG RECEPTOR BINDING; GENE AMPLIFICATION; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNALIZATION; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL; VIREMIA; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0032125533     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199807010-00005     Document Type: Article

References (18)

1. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996;384:529-34.
2. Cocchi F, DeVico AL, Garzino Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1 alpha and MIP-1 beta as the major HIV-suppressive factors produced by CD8(+) T cells. Science 1995;720:1811-15.
3. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV 1 coreceptor accounts for resistance of some multiply exposed individuals to HIV 1 infection. Cell 1996;86:367-77.
4. Michael NL, Chang G, Louie LG, et al. The role of viral phenotype and CCR 5 gene defects in HIV 1 transmission and disease progression. Nature Med 1997;3:338-40.
5. Huang Y, Paxton WA, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med 1996;2:1240-3.
6. Dean M, Carrington M, Goedert J, O'Brian SJ. Genetic restriction of HIV 1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;274:1069.
7. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV 1 infection in Caucasian individuals bearing mutant alleles of the CCR 5 chemokine receptor gene. Nature 1996;382:722-5.
8. Phair JP. Keynote address: variations in the natural history of HIV infection. AIDS Res Hum Retroviruses 1994;10:883-5.
9. Pantaleo G, Fauci AS. New concepts in the immunopathogenesis of HIV infection. Annu Rev Immunol 1995;13:487-512.
10. Sambrock J. Extraction of genomic DNA. In Sambrock J, Fritsch EF, Maniatis T, eds. Molecular cloning. New York: Cold Spring Harbor Laboratory Press, 1989:E12-13.
11. Rosner B. Fundamentals of biostatistics, 3rd ed. Boston: PWS-Kent Publishing, 1990:304-9.
12. Biti R, French RF, Young J, Bennetts B, Stewart G, Liang T. HIV 1 infection in an individual homozygous for the the CCR5 deletion allele. Nature Med 1997;3:252-3.
13. O'Brien TR, Winkler C, Dean M, et al. HIV 1 infection in a man homozygous for CCR5 Delta 32. Lancet 1997;349:1219.
14. Theodorou I, Meyer L, Magierowaka M, Katlama C, Rouzioux C. HIV 1 infection in an individual homozygous for CCR5 Delta 32. Lancet 1997;349:1219-20.
15. Mellors JW, Rinaldo CR Jr., Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70
16. + lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med 1996;334:426-31.
17. Muhlhofer A, Bogner JR, Goebel FD. The HIV viral load: new aspects and limits of its clinical use. Dtsch Med Wochenschrift 1996;121:1303-8.
18. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell lifespan, and viral generation time. Science 1996;271:1582-6.